Pivot X, Spano JP, Espie M, Jouannaud C, et al. Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer. Clin Breast Cancer 2023 Jun 20:S1526-8209(23)00164.
PMID: 37423801